Wolters Kluwer Health, a leading global provider of information for healthcare professionals and students, announced today that it has released the Medi-Span® Federal Government Pricing File™, which consolidates NADAC pricing data from CMS, serving as a key resource to payers, pharmacy benefit managers, and retail pharmacies.
In late November, the Centers for Medicare & Medicaid Services (CMS) released the first publication of the National Average Drug Acquisition Cost (NADAC), a new national benchmark reflective of the prices pharmacies pay to acquire outpatient prescription and OTC medications. Medi-Span has developed the Federal Government Pricing File that reports NADAC pricing information, allowing Medi-Span customers to easily utilize the new pricing information for their business needs. Additionally, the file also extrapolates pricing to similar NDCs that are not reported by CMS, providing a more robust picture of affected NDCs reported by Medi-Span. The extrapolated NDCs are readily identified and distinguished from the CMS-based NDCs.
“Being a leader in the drug pricing industry with thousands of users worldwide in the payer, PBM, and retail pharmacy markets, Medi-Span understands the industry’s needs,” commented David Del Toro, Vice President & General Manager, Clinical Drug Information, Wolters Kluwer Health, Clinical Solutions. “Coupled with the talented group of professionals on our Product and Development teams, we not only take that understanding and quickly provide our customers with the highly-anticipated NADAC pricing data, but to also foresee the need for extrapolated data on medications not yet identified by CMS and offer that data as well to provide a complete picture of the NADAC price.”